BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 23567516)

  • 1. Peripheral blood natural killer (NK) cell function in healthy adults assessed using the target-induced NK loss (TINKL) assay.
    Warren HS; Wu F; Horn PL; Pyne DB; West NP; Cripps AW
    J Immunol Methods; 2013 Jun; 392(1-2):68-70. PubMed ID: 23567516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Target-induced natural killer cell loss as a measure of NK cell responses.
    Warren H
    Curr Protoc Immunol; 2012 Apr; Chapter 14():Unit 14.29.1-15. PubMed ID: 22470134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Target-induced natural killer cell loss as a measure of NK cell responses.
    Warren HS
    J Immunol Methods; 2011 Jul; 370(1-2):86-92. PubMed ID: 21689658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An improved flow cytometry-based natural killer cytotoxicity assay involving calcein AM staining of effector cells.
    Jang YY; Cho D; Kim SK; Shin DJ; Park MH; Lee JJ; Shin MG; Shin JH; Suh SP; Ryang DW
    Ann Clin Lab Sci; 2012; 42(1):42-9. PubMed ID: 22371909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A MitoTracker Green-based flow cytometric assay for natural killer cell activity: variability, the influence of platelets and a comparison of analytical approaches.
    Hopkinson K; Williams EA; Fairburn B; Forster S; Flower DJ; Saxton JM; Pockley AG
    Exp Hematol; 2007 Mar; 35(3):350-7. PubMed ID: 17309815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel five-colour flow cytometric assay to determine NK cell cytotoxicity against neuroblastoma and other adherent tumour cells.
    Klöss S; Bochennek K; Huenecke S; Zimmermann SY; Kuçi S; Müller T; Wels WS; Klingebiel T; Esser R; Koehl U
    J Immunol Methods; 2007 Aug; 325(1-2):140-7. PubMed ID: 17663991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of norepinephrine-mediated inhibition of human NK cytotoxic functions: inhibition of cytokine secretion, target binding, and programming for cytotoxicity.
    Gan X; Zhang L; Solomon GF; Bonavida B
    Brain Behav Immun; 2002 Jun; 16(3):227-46. PubMed ID: 12009684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term killing of natural killer-resistant target cells by interferon-alpha-, interferon-gamma-, and interleukin-2-activated natural killer cells.
    Sarzotti M; Klimpel GR; Baron S
    Nat Immun Cell Growth Regul; 1989; 8(2):66-75. PubMed ID: 2503715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Target-induced natural killer cell loss as a measure of NK cell responses.
    Warren H
    Curr Protoc Immunol; 2013; Chapter 14():Unit 14.29.1-21. PubMed ID: 23564684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro generation of human activated lymphocyte killer cells: separate precursors and modes of generation of NK-like cells and "anomalous" killer cells.
    Burns GF; Triglia T; Werkmeister JA
    J Immunol; 1984 Sep; 133(3):1656-63. PubMed ID: 6611374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation of the EGFP-K562 flow cytometric NK test: determination of NK cytotoxic activity in healthy elderly volunteers before and after feeding.
    Allegra S; Deleine C; Michael-Jubely R; Gryson C; Boirie Y; Kantakamalakul W; Vasson MP
    Cytometry A; 2006 Sep; 69(9):992-8. PubMed ID: 16969797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of NK activity in whole blood by the CD69 up-regulation after co-incubation with K562, comparison with NK cytotoxicity assays and CD107a degranulation assay.
    Dons'koi BV; Chernyshov VP; Osypchuk DV
    J Immunol Methods; 2011 Sep; 372(1-2):187-95. PubMed ID: 21839083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid flow cytometry based cytotoxicity assay for evaluation of NK cell function.
    Mhatre S; Madkaikar M; Ghosh K; Desai M; Pujari V; Gupta M
    Indian J Exp Biol; 2014 Oct; 52(10):983-8. PubMed ID: 25345247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural killer cells in normal pregnancy: analysis using monoclonal antibodies and single-cell cytotoxicity assays.
    Gregory CD; Lee H; Rees GB; Scott IV; Shah LP; Golding PR
    Clin Exp Immunol; 1985 Oct; 62(1):121-7. PubMed ID: 3864569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced release and binding of perforin at the immunological synapse underlies the age-related decline in natural killer cell cytotoxicity.
    Hazeldine J; Hampson P; Lord JM
    Aging Cell; 2012 Oct; 11(5):751-9. PubMed ID: 22642232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Wilms tumor cell line, HFWT, can greatly stimulate proliferation of CD56+ human natural killer cells and their novel precursors in blood mononuclear cells.
    Harada H; Watanabe S; Saijo K; Ishiwata I; Ohno T
    Exp Hematol; 2004 Jul; 32(7):614-21. PubMed ID: 15246157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
    Bonavida B; Lebow LT; Bradley TP
    J Immunol; 1984 Feb; 132(2):594-8. PubMed ID: 6606675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of NK activity by the microcytotoxicity assay (MCA): a new application for an old assay.
    Wahlberg BJ; Burholt DR; Kornblith P; Richards TJ; Bruffsky A; Herberman RB; Vujanovic NL
    J Immunol Methods; 2001 Jul; 253(1-2):69-81. PubMed ID: 11384670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts.
    Baba M; Hasegawa H; Nakayabu M; Fukai K; Suzuki S
    J Clin Lab Immunol; 1993; 40(2):47-60. PubMed ID: 7932628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expansion of natural killer (NK) and natural killer-like T (NKT)-cell populations derived from patients with B-chronic lymphocytic leukemia (B-CLL): a potential source for cellular immunotherapy.
    Guven H; Gilljam M; Chambers BJ; Ljunggren HG; Christensson B; Kimby E; Dilber MS
    Leukemia; 2003 Oct; 17(10):1973-80. PubMed ID: 14513047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.